Pharma Deal-making: A forward-looking study on deal term expectations and trends
We invite you to participate in L.E.K. Global Healthcare Insights Center’s inaugural study that takes a closer look at how pharma and biotech dealmakers negotiate deal terms across various therapeutic areas. The aim of the study is to better understand the driving behaviors and deal term expectations at time of negotiation as well as explore future trends across the landscape.
We know your time is valuable and we are offering an honorarium of $100 and a preview summary of the study results for your participation if you are allowed to accept such payments by your organization. Even if you are not able to accept compensation, we would value your opinions regarding this topic.
If interested, please find the survey participation link: Click Here
|
Thank you in advance; your input is highly valued!
Disclaimers: If you qualify, you will receive a virtual prepaid VISA card sent to your email address ~2-3 weeks after completion of the survey. A payment will only be made to individuals who qualify and complete the entire survey. All information you provide will be aggregated with responses from other survey participants.
L.E.K Consulting, in the ordinary course of its business, will collect, store, use and transfer within L.E.K. Consulting your contact information (including, but not limited to your name, title and/or position, postal address, telephone numbers, e-mail addresses and any other information we may attach to your contact profile) so that we may contact you in connection with any potential interview opportunities or participation in surveys that may arise in the context of our business activities, where your input may be sought, as well as to process honoraria payments for which you may be eligible.
For information on how we process your personal data in this context and the rights that you may have please see our Privacy Notice. |
|
